Xanamem: Alzheimer’s breakthrough set for 2025, 2026
The search for an effective treatment for neurological conditions like Alzheimer’s disease…
Actinogen Medical Limited (ASX:ACW)
About Actinogen Medical Limited
Key Information
ACW In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 11.04am 19/05/2025 | Actinogen CMO presents positive depression data at APA 2025 | 441.55KB | 162 |
| 15/05/2025 | ACW Science Forum today - Preparing for commercialization | 1.88MB | 11K |
| 30/04/2025 | Price Sensitive PS Actinogen March 2025 quarterly activity report & Appendix 4C | 512.41KB | 6.6K |
| 24/04/2025 | ACW Science Forum notice - Preparing for commercialization | 219.93KB | 541 |
| 23/04/2025 | Change in substantial holding | 216.67KB | 6.6K |
| 02/04/2025 | ACW CMO presents Xanamem pTau poster at ADPD25 conference | 604.16KB | 696 |
| 27/03/2025 | Price Sensitive PS ACW conducts Type C meeting with FDA regarding depression | 236.28KB | 739 |
| 26/03/2025 | Actinogen presentation to ASX small & mid-caps conference | 1.38MB | 6.8K |